Lung and colon cancers are two of the most common malignancies, which, in some cases, may develop synchronously. In the present study, the treatment and outcome of patients with synchronous lung and colon cancers were reviewed. During a 76‑month study period, from April 2009 up to July 2016, 17 (0.54%) of 3,102 patients with lung cancer were diagnosed with colon cancer within 1 month. Heavy smoking and obesity were not specific factors in these patients. A total of 9 patients succumbed to lung cancer during the study period. Survival in asymptomatic patients was longer compared with that in symptomatic patients (median survival, 80 vs. 23.2 months, respectively; P=0.007). Although the incidence of synchronous occurrence of these two cancers...
Introduction. Lung cancer and chronic obstructive pulmonary disease (COPD) are one of the most signi...
Synchronous colorectal cancer is a rare condition, which presents with the simultaneous development ...
Colorectal cancer is one of the most common malignant neoplasms worldwide. Overall mortality is 33%....
The incidence of synchronous colorectal and lung cancer is relatively rare. We report three cases of...
The incidence of synchronous colorectal and lung cancer is relatively rare. We report three cases of...
Synchronous colorectal neoplasias, defined as 2 or more primary tumors identified in the same patien...
BACKGROUND: A noticeable proportion of colorectal cancer (CRC) patients are diagnosed with synchrono...
According to literature the synchronous malignant tumors of the colon are 2-11% from all cases of sp...
AIMS: The purpose of this study was to investigate the clinical characteristics of synchronous cance...
Background: Synchronous colorectal carcinoma has seldom been studied in large series. The study wa...
Colorectal cancer is the second leading cause of cancer-related deaths in the United States amongst ...
Any two or more primary malignant tumors, in which each tumor is not an extension, recurrence, or me...
In a series of 1,037 patients with colorectal carcinoma diagnosed at one hospital during a 9-year pe...
Epithelial tumors synchronous with hematologic malignancies are very rare. The hystopathologic type ...
The authors report on 30 synchronous cancer (19%) and 9 metachronous cancer (5.7%) observed in 5 yea...
Introduction. Lung cancer and chronic obstructive pulmonary disease (COPD) are one of the most signi...
Synchronous colorectal cancer is a rare condition, which presents with the simultaneous development ...
Colorectal cancer is one of the most common malignant neoplasms worldwide. Overall mortality is 33%....
The incidence of synchronous colorectal and lung cancer is relatively rare. We report three cases of...
The incidence of synchronous colorectal and lung cancer is relatively rare. We report three cases of...
Synchronous colorectal neoplasias, defined as 2 or more primary tumors identified in the same patien...
BACKGROUND: A noticeable proportion of colorectal cancer (CRC) patients are diagnosed with synchrono...
According to literature the synchronous malignant tumors of the colon are 2-11% from all cases of sp...
AIMS: The purpose of this study was to investigate the clinical characteristics of synchronous cance...
Background: Synchronous colorectal carcinoma has seldom been studied in large series. The study wa...
Colorectal cancer is the second leading cause of cancer-related deaths in the United States amongst ...
Any two or more primary malignant tumors, in which each tumor is not an extension, recurrence, or me...
In a series of 1,037 patients with colorectal carcinoma diagnosed at one hospital during a 9-year pe...
Epithelial tumors synchronous with hematologic malignancies are very rare. The hystopathologic type ...
The authors report on 30 synchronous cancer (19%) and 9 metachronous cancer (5.7%) observed in 5 yea...
Introduction. Lung cancer and chronic obstructive pulmonary disease (COPD) are one of the most signi...
Synchronous colorectal cancer is a rare condition, which presents with the simultaneous development ...
Colorectal cancer is one of the most common malignant neoplasms worldwide. Overall mortality is 33%....